The approval of the additional variants of Nasal Swab is timely as the Malaysian government has made it mandatory for all foreign workers to be COVID-19 tested commencing 1 January 2021. The Ministry of Health, Malaysia has also stepped up efforts to do mass screening in targeted hotspots in an attempt to curb COVID-19 infections. The demand for Nasal Swab is expected to increase in tandem with the rise in COVID-19 testing and the K-One Group is prepared to meet the surge in uptake.
The Question here is how come the COO and the staffs had disposed their shares before the anouncement. My friend told me that got anoucement. Today really got an anouncement. What is the point of such a oicemebt if no actual sales or contract. Maybe these is another trap
Honlee, the two guys oledi sell off and suffer huge loss, that's why they keep on comment bad thing here. If the price up they feel uncomfortable, if price down they will happy
May be the employees of K1 will take this opportunity to offload , let's monitor for the next two days. Based on previous announcements , they sold on the 2nd day after the news was out .That might be the cause why the price dropped after the news.
This time is genuine with sales draw in that will lead to positive revenue... Eventually the share price will move according to the basic business of one company... This is also the most basic concept of value investment concept
Today's announcement will be used to push up early morning, insider will sell to retailers chasing high and they kena trap again when price pancit leading to gradual decline over 3 days until force selling over. Same pattern over and over again but still works on unsuspecting retailers
know i know share price drop maybe nasal swab cannot detect new variant mutate. during do nasal swab detect old covid. now at UK new variant. sudah mula merebak
Think Nasal swab can detect . Otherwise how they know got new mutation. Only thing we don know now is the effectiveness of the vaccine towards the new mutated virus.
As she vacine is still new with lots of uncertainties ..I think swab test will still be needed even after vacination to check if indeed the vaccines is working . Let's hope market take note of k1 tomorrow onwards. Good luck all
K1 business is not supplying nasal swab, manufacturing and supplying nasal swab is just one of many new business K1 is starting. Their cloud business started 2 years ago is flourishing. 2 years ago pricing was hovering 20+-sen. Cash surplus, profitable business and we have people here calling for sell? Just buy.
K One Technology Bhd has linked a licence agreement with UK-based that call syringe cap. but new Virus at UK. Vaccine UK all AstraZenca. If Vaccine have then syringe cap is compulsory
last report said that the syringe cap should be ready for mass production from Q1 2021. Hope the management doing their best to expedite to catch this huge wave of demand..
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
lalam2017
448 posts
Posted by lalam2017 > 2020-12-30 14:50 | Report Abuse
If the company got the potential, I am sure they won't sell. Common sense tell...